×

EVIGATOR 1

What we do 1 What sets us apart 1 Our solutions 1 What we think 1
×

Global RWE 2

What we do 2 What sets us apart 2 Our solutions 2 What we think 2
×

Strategic Services 3

What we do 3 What sets us apart 3 Our solutions 3 What we think 3
0
Skip to Content
GIPAM
Why GIPAM
About
Corporate Responsibility
Careers
Services
Strategic Services
Global RWE
Evidence Synthesis
ANCHOR
ONCOCASE
EVIGATOR
Insights
News
Whitepapers & Publications
Events & Webinars
Contact
Subscribe to Newsletter
Shop
GIPAM
Why GIPAM
About
Corporate Responsibility
Careers
Services
Strategic Services
Global RWE
Evidence Synthesis
ANCHOR
ONCOCASE
EVIGATOR
Insights
News
Whitepapers & Publications
Events & Webinars
Contact
Subscribe to Newsletter
Shop
Folder: Why GIPAM
Back
About
Corporate Responsibility
Careers
Folder: Services
Back
Strategic Services
Global RWE
Evidence Synthesis
ANCHOR
ONCOCASE
EVIGATOR
Folder: Insights
Back
News
Whitepapers & Publications
Events & Webinars
Contact
Subscribe to Newsletter
Shop
Shop Network meta-analysis (NMA)
Online Shop images-1-Consulation .png Image 1 of
Online Shop images-1-Consulation .png
Online Shop images-1-Consulation .png

Network meta-analysis (NMA)

€66,800.00

NMA conducted to HTA and publication standards.

Designed for: HTA submissions, reimbursement dossiers, and peer-reviewed publication.

Scope: Comprehensive NMA using all available evidence to compare interventions within clinically relevant networks defined by PICO.

Compliance: Methodology aligned with international HTA (CDA, NICE, EU JCA) and publication requirements (PRISMA-NMA).

Process: Development of a comprehensive statistical analysis plan (SAP) to meet robust reporting requirements for ITC justification and analytical methods. Analyses conducted based on formalized SAP with results presented for internal review.

Output: Technical report and/or publication-ready manuscript, including network diagrams, forest plots, relative treatment effects, and results tables. Structured to meet HTA submission and journal requirements.

Timeline: 6 weeks

Quantity:
Add To Cart

NMA conducted to HTA and publication standards.

Designed for: HTA submissions, reimbursement dossiers, and peer-reviewed publication.

Scope: Comprehensive NMA using all available evidence to compare interventions within clinically relevant networks defined by PICO.

Compliance: Methodology aligned with international HTA (CDA, NICE, EU JCA) and publication requirements (PRISMA-NMA).

Process: Development of a comprehensive statistical analysis plan (SAP) to meet robust reporting requirements for ITC justification and analytical methods. Analyses conducted based on formalized SAP with results presented for internal review.

Output: Technical report and/or publication-ready manuscript, including network diagrams, forest plots, relative treatment effects, and results tables. Structured to meet HTA submission and journal requirements.

Timeline: 6 weeks

NMA conducted to HTA and publication standards.

Designed for: HTA submissions, reimbursement dossiers, and peer-reviewed publication.

Scope: Comprehensive NMA using all available evidence to compare interventions within clinically relevant networks defined by PICO.

Compliance: Methodology aligned with international HTA (CDA, NICE, EU JCA) and publication requirements (PRISMA-NMA).

Process: Development of a comprehensive statistical analysis plan (SAP) to meet robust reporting requirements for ITC justification and analytical methods. Analyses conducted based on formalized SAP with results presented for internal review.

Output: Technical report and/or publication-ready manuscript, including network diagrams, forest plots, relative treatment effects, and results tables. Structured to meet HTA submission and journal requirements.

Timeline: 6 weeks

You Might Also Like

SLR on Clinical Efficacy for Health Technology Assessments
SLR on Clinical Efficacy for Health Technology Assessments
€168,252.00
Automated SLR protocol
Automated SLR protocol
€3,850.00
Feasibility assessment for indirect treatment comparisons (ITCs)
Feasibility assessment for indirect treatment comparisons (ITCs)
€35,000.00
Automated study listing
Automated study listing
€5,700.00
Targeted Literature Review (TLR) [small]
Targeted Literature Review (TLR) [small]
€50,133.00

Do you have questions?

CONTACT US >

Contact Us

GIPAM GmbH

Alter Holzhafen 19

23966 Wismar, Germany

Phone: +49 3841 758 1014

info@gipam-health.com

Shop Form
Please provide your contact details and we will contact you about your wishlist
Name *

Thank you for your submission.

As you’ll likely need a full contract, we’ll send you a draft within the next 48 working hours. Once received, please review the draft carefully. If you're happy to proceed, you can either sign it directly or let us know if you’d prefer to use an electronic signature process.

Should you have any feedback or request changes, we’re happy to consider them—please email Sabrina at sabrina.mueller@gipam-health.com.

Once the contract is signed, our project manager will be in touch right away to schedule your kick-off meeting.

Our Services

Strategic Services

Global RWE

Evidence Synthesis

Ask me about RWE

Learn more

News & Seminars

Whitepapers & Publications

About Us

Corporate Responsibility

Code of Conduct

Privacy Policy

Cookie Policy

Terms of Use

Connect